$96.5m settlement proposed in Provigil pay-for-delay case

06-02-2017

Mylan has been offered a settlement to pay $96.5 million in a pay-for-delay case over Provigil (modafinil), a drug produced by Cephalon which reduces extreme sleepiness due to narcolepsy.


pay-for-delay, Provigil, Mylan, Cephalon, patent

LSIPR